INS and polycystic ovary syndrome: Our findings indicate that, unlike a previous study employing an insulin-sensitizing agent to lower circulating insulin levels and normalize ovulatory menstrual cycles in PCOS-like female monkeys [86], we found no evidence for a role of elevated circulating insulin levels in the mechanism of PCOS pathogenesis.